Related Experiment Video
Updated: Jan 31, 2026

Echocardiographic and Histological Examination of Cardiac Morphology in the Mouse
Published on: October 26, 2017
A histopathologic schema to quantify the burden of cardiac amyloidosis: Relationship with survival and
Priya Mehta1, David B Chapel1, Neha Goyal1
1Departments of Medicine, University of Chicago, Chicago, Illinois.
Insights
Cardiac amyloidosis (CA) burden impacts survival. Echocardiography parameters correlate with CA burden, offering potential prognostic insights. Further research is needed to validate these imaging biomarkers.
Area of Science:
- Cardiology
- Pathology
- Medical Imaging
Background:
- Echocardiographic parameters for cardiac amyloidosis (CA) severity lack validation.
- A histopathologic schema was developed to quantify CA burden.
- The relationship between CA burden and clinical outcomes was evaluated.
Purpose of the Study:
- To validate echocardiographic parameters for assessing cardiac amyloidosis (CA) burden.
- To correlate histopathologic CA burden with clinical outcomes.
- To explore echocardiographic parameters as noninvasive indices of CA burden.
Main Methods:
- Retrospective study of 59 patients with CA (light chain and transthyretin types).
- Endomyocardial biopsies analyzed using light microscopy with staining to categorize CA burden (mild-to-moderate vs. high).
- Echocardiographic parameters (EF, IVSt, PWt, LV mass, e'-velocity, GLS) measured and compared between groups.
Main Results:
- 24 patients had high CA burden, associated with worse mortality, particularly in transthyretin-type CA.
- Echocardiography-derived IVSt, PWt, and LV mass positively correlated with CA burden.
- LV EF, e'-velocity, and GLS magnitude inversely correlated with CA burden.
Conclusions:
- CA burden is clinically significant and offers prognostic information.
- Echocardiographic parameters of LV anatomy and function correlate with histopathologic CA burden.
- Further studies are needed to establish echocardiography as a biomarker for treatment response in CA.
Background:
Despite routine use of echocardiographic parameters to evaluate the severity of cardiac amyloidosis (CA), this methodology has not been well validated. We developed a histopathologic schema for quantifying CA burden and evaluated its relationship with clinical outcomes. Additionally, echocardiographic parameters were tested as potential noninvasive indices of CA burden.
Methods:
We retrospectively studied 59 patients with CA (17 light chain, 42 transthyretin) who underwent endomyocardial biopsies. Light microscopy with staining was used to categorize CA burden as mild-to-moderate (<50%) or high (≥50%). Kaplan-Meier survival analysis was performed for the two groups. In 34 patients with good-quality echocardiograms, we measured left ventricular volumes, ejection fraction (EF), interventricular septal thickness (IVSt), posterior wall thickness (PWt), LV mass, lateral e'-velocity, and global longitudinal strain (GLS). These parameters were compared between the two groups.
Results:
Thirty-five patients had mild-to-moderate and 24 severe amyloid burden. Kaplan-Meier curves demonstrated a trend toward worse mortality with high CA burden, which was more common and associated with higher mortality specifically in transthyretin-type patients. Echocardiography-derived IVSt, PWt, and LV mass were directly related to CA burden, while LV EF, e'-velocity, and GLS magnitude were inversely related to CA burden.
Conclusions:
Our findings provided a signal that CA burden is a clinically important entity with potentially valuable prognostic information. Echocardiographic parameters of LV anatomy and function correlate with histopathologic burden of CA, which is inversely related to survival. Further studies are needed to determine whether these parameters could be used as imaging biomarkers of treatment-related changes in CA burden.
More Related Videos
Related Concept Videos
Self-Schemas
Schemas
Impact of Schemas
Relationship Formation
Ending Relationships
Survival Curves
The Kaplan-Meier estimator is the most common method for constructing survival curves. This...

